April 26, 2017

No Image

Trump Tells Canada And Mexico He Will Renegotiate, Not Withdraw From NAFTA

Trucks travel on an overpass to and from the World Trade Bridge which links Laredo, Texas, and Nuevo Laredo in the Mexican state of Tamaulipas.

Eric Gay/AP

hide caption

toggle caption

Eric Gay/AP

Following news reports Wednesday that the Trump administration intended to begin the process of withdrawing from the North American Free Trade Agreement, or NAFTA, the White House said President Trump reassured the leaders of Canada and Mexico by phone that the U.S. had no immediate plans to do so.

A White House statement issued late Wednesday night said that Trump had spoken by phone with both Mexican President Enrique Peña Nieto and Canadian Prime Minister Justin Trudeau.

The full White House statement:

“Late this afternoon, President Donald J. Trump spoke with both President Peña Nieto of Mexico and Prime Minister Trudeau of Canada. Both conversations were pleasant and productive. President Trump agreed not to terminate NAFTA at this time and the leaders agreed to proceed swiftly, according to their required internal procedures, to enable the renegotiation of the NAFTA deal to the benefit of all three countries. President Trump said, ‘it is my privilege to bring NAFTA up to date through renegotiation. It is an honor to deal with both President Peña Nieto and Prime Minister Trudeau, and I believe that the end result will make all three countries stronger and better.’ “

The Associated Press reports:

“The White House announcement came hours after administration officials said Trump was considering a draft executive order to withdraw the U.S. from the deal — though administration officials cautioned it was just one of a number of options being discussed by the president and his staff.

“Some saw the threat as posturing by Trump to gain leverage over Mexico and Canada as he tries to negotiate changes to the deal. Trump railed against the decades-old trade deal during his campaign, describing it as a ‘disaster.’ “

The AP reports that both the Mexican and Canadian governments confirmed the conversations had taken place.

As first reported by Politico, White House officials had drafted an executive order to begin the process of withdrawing from NAFTA. The reports were followed by a sharp drop in the value of the Mexican peso against the U.S. dollar. The Canadian dollar also fell, though not as sharply.

Let’s block ads! (Why?)


No Image

Today in Movie Culture: New 'Alien: Covenant' Prologue, FaceApp Gets a Movie-Themed Parody and More

Here are a bunch of little bites to satisfy your hunger for movie culture:

Prologue of the Day:

Ahead of the release of Alien: Covenant, here’s a new prologue showing what happened to Elizabeth and David after the end of Prometheus (via /Film):

[embedded content]

Alternate Ending of the Day:

How might Star Wars: The Force Awakens have ended more happily? The Unusual Suspect presents a clever mashup with Raiders of the Lost Ark footage:

[embedded content]

Cosplay of the Day:

Speaking of Star Wars, awesome Star Wars Celebration cosplay is still coming in, like this trio as high school versions of Han, Leia and Luke doing the Breakfast Club dance (via Fashionably Geek):

Prank of the Day:

Also from Star Wars Celebration, here’s a video of John Boyega surprising fans to help promote Force for Change (via Geek Tyrant):

[embedded content]

Phone App Parody of the Day:

FaceApp is so popular now that we’re seeing movie-themed parodies like this one inspired by Face/Off:

I love this new FaceApp update pic.twitter.com/CgSr2gIyAn

— Super Deluxe (@superdeluxe) April 26, 2017

DIY Prop Replica of the Day:

Want to own Maui’s hook from Moana but you can’t becuase that’s a cartoon? Here’s AWE with a tutorial on how to make your own:

[embedded content]

Vintage Image of the Day:

Jonathan Demme, who passed away today, directs Anthony Hopkins on the set of The Silence of the Lambs:

Supercut of the Day:

Filmscalpel looks at great silent moment in the era of sound in this supercut featuring The Matrix, 2001: A Space Odyssey, Lost in Translation and more (via Film School Rejects):

[embedded content]

Location Celebration of the Day:

The old Penn Station in New York City is gorgeous and fortunately we can still see what it looked like in the movies collected in this Fandor video:

[embedded content]

Classic Trailer of the Day:

This week is the 20th anniversary of the release of Volcano. Watch the original teaser trailer for the classic disaster movie below.

[embedded content]

and

Let’s block ads! (Why?)


No Image

First Listen: 'The Ecstatic Music of Alice Coltrane Turiyasangitananda'

The Ecstatic Music of Alice Coltrane Turiyasangitananda is out May 5.

Courtesy of the artist

hide caption

toggle caption

Courtesy of the artist

Multi-instrumentalist, composer, spiritual leader and the wife of John Coltrane, Alice Coltrane Turiyasangitananda (1937-2007) long stood in her husband’s shadow. Some certain number of more casual jazz fans, if they have known her name at all, only know it from sidewoman credits on some of his albums, and not for her own performances and recordings.

But even many more ardent fans who know her string of recordings for Impulse and Warner Bros. in the 1970s don’t know the music she created in the last two decades of her life — music that was not necessarily meant for widespread consumption: the Hindu devotional songs that she recorded as a spiritual leader and the head of an ashram near Los Angeles.

John and Alice had fallen in love in 1963; in short order, they married and had four children together: Michelle, John Jr., Ravi and Oranyan (also known as Oran). Within four years of their marriage, however, John Coltrane died of liver cancer. He was just 30 years old. Like her husband, Alice Coltrane was a spiritual seeker; not long after his death, she met Swami Satchidananda — the guru who opened the Woodstock festival — and became his disciple. Her own compositional language evolved during those years into an intoxicating, highly unusual blend of jazz, blues and Indian instruments and tonalities. Her life as a spiritual leader also grew during those years, and she founded The Vedanta Center in 1975.

Coltrane’s life took another sharp turn when, in 1982, their eldest son, John Jr., was killed in a car accident at age 18. With her religious beliefs for sustenance after that tragedy and with a growing following of her own, she founded the Sai Anantam Ashram the following year, which became a 48-acre compound in Agoura Hills, Calif.

Despite Coltrane’s withdrawal from her secular career, music was still at the heart of her religious practice. Even the Hindu name she took on — “Turiyasangitananda” — has music embedded in its core. Sangit, or sangeet, is “music” in Sanskrit; she translated her adopted name as “the transcendental lord’s highest song of bliss.” (Her followers and friends simply called her “Turiya” or “Swamini,” the title for a female teacher.)

It was a good match between spirit and spiritual path. In the Hindu tradition, the entire universe, the cycles of birth, life, destruction, silence and renewal are all encompassed with the sound of “aum” (or “om,” as it’s more commonly transliterated into English) — and there is a deep, long tradition of expressing love for the divine through songs, whether bhajans (individual songs of devotion), kirtans (call-and-response worship songs) or even in the classical tradition, in which ancient devotional songs are the texts for sung ragas.

In the music she created for her religious community, Coltrane – unsurprisingly – did not simply mimic Indian tradition when it came to singing praises to Hindu deities at her ashram’s mandir, or temple. She created something wholly new, and completely her own. The Ecstatic Music of Alice Coltrane Turiyasangitananda are a powerful and indelibly personal mix of the soulful gospel cadences that Coltrane had been steeped in since her church-going childhood in Detroit, and the brimming, collective energy of the call-and-response kirtans. At the ashram’s Sunday services, “She would start playing music and everyone else would join in and they might go two, three, four hours of doing that,” recalls Coltrane’s nephew, musician and producer Flying Lotus (birth name Steven Ellison), in this collection’s extensive liner notes.

The songs on this compilation are culled from four recordings Coltrane made in the 1980s and ’90s on a series of self-released cassettes that were meant primarily for an audience of her followers. (The label for this reissue, Luaka Bop, calls it the first volume in a series called World Spirituality Classics.) Texturally, these compositions exist on several planes simultaneously: they are grounded by Coltrane’s rich, darkly hued, deeply resonant voice (which she had never deployed on her secular recordings); swept along in the currents of her followers’ voices, their hand-held percussion, and her harp and organ; and lifted straight into the cosmic stratosphere by the synthesizers that she had come to love in her later years.

It’s already been argued that a new generation of listeners will be tempted to delve into these devotional songs as zone-out sounds, “ambient music with a purpose” that squares nicely with our era of yoga studios and pressed juices for sale on every block. But this is music that – just as in both the traditional gospel and Hindu devotional styles – demands participation: The particulars of what or who you believe in (or don’t) may not even matter. Either you’re going to be using your voice to sing along, or your heart.

The Ecstatic Music of Alice Coltrane Turiyasangitananda comes out May 5.

Courtesy of the artist

First Listen: The Ecstatic Music of Alice Coltrane Turiyasangitananda

01Om Rama

9:39

  • <iframe src="https://www.npr.org/player/embed/525541596/525594089" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

    02Om Shanti

    6:52

    • <iframe src="https://www.npr.org/player/embed/525541596/525594182" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

      03Rama Rama

      7:35

      • <iframe src="https://www.npr.org/player/embed/525541596/525594260" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

        04Rama Guru

        5:53

        • <iframe src="https://www.npr.org/player/embed/525541596/525594303" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

          05Hari Narayan

          4:39

          • <iframe src="https://www.npr.org/player/embed/525541596/525594353" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

            06Journey To Satchidananda

            10:53

            • <iframe src="https://www.npr.org/player/embed/525541596/525594463" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

              07Er Ra

              5:00

              • <iframe src="https://www.npr.org/player/embed/525541596/525594596" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

                08Keshava Murahara

                9:44

                • <iframe src="https://www.npr.org/player/embed/525541596/525594697" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

                  Let’s block ads! (Why?)


                  No Image

                  Overlooked Drug Could Save Thousands Of Moms After Childbirth

                  Postpartum hemorrhage is the leading cause of maternal deaths around the world.

                  Thomas Fredberg/Getty Images/Science Photo Library

                  hide caption

                  toggle caption

                  Thomas Fredberg/Getty Images/Science Photo Library

                  Back in the 1960s, a woman doctor in Japan created a powerful drug to help mothers who hemorrhage after childbirth.

                  The medicine is inexpensive to make. Safe to use. And stops bleeding quickly by helping keep naturally forming blood clots intact.

                  The drug’s inventor, Utako Okamoto, hoped the drug called tranexamic acid would be used to help save moms’ lives.

                  Every year about 100,000 women around the world die of blood loss soon after a baby is born. It’s the biggest cause of maternal death worldwide.

                  “It was Okamoto’s dream to save women,” says Haleema Shakur, who directs clinical trials at London School of Tropical Medicine and Hygiene. “But she couldn’t convince doctors to test the drug on postpartum hemorrhaging.”

                  And so tranexamic acid has gone largely unused in maternity wards for decades.

                  Until now.

                  In a massive international trial, Shakur and her collaborators have shown that tranexamic acid decreased the risk of death from blood loss associated with childbirth by about a third. (Previous studies have looked at the drug’s use in reducing bleeding deaths after traumatic injuries.)

                  In the study, women who were diagnosed with heavy bleeding, or postpartum hemorrhage, after a vaginal birth or cesarean sectionreceived either the drug or a placebo.

                  About 1.2 percent of women who got tranexamic acid within three hours of a hemorrhage died, compared with 1.7 percent of the women who got the placebo.

                  Side effects weren’t a serious problem. The medicine didn’t increase the risk of dying of other causes during the procedure, Shakur and her colleagues report in The Lancet journal.

                  The study included 20,000 women, in nearly 200 hospitals, across 21 countries, including rich ones, like the U.K., and poorer ones, like Pakistan and Nigeria.

                  The medicine is inexpensive. It cost about $3 in the U.K., and a quarter of that in Pakistan, for instance.

                  “If you can save a life for approximately $3, then I believe that’s worth doing,” Shakur says.

                  It’s rare to have a new tool for helping women during childbirth, says Felicia Lester, an OB-GYN at the University of California, San Francisco, who also works in Uganda and Kenya.

                  “I think the study is exciting,” she says. “I’m usually cautious in saying that. But it looks like tranexamic acid has the potential to save lives.”

                  The drug even helped women when doctors used it along with other common medications, such as oxytocin, says Margaret Kruk, a global health researcher at Harvard University.

                  “Tranexamic acid offers an additional benefit above and beyond what is being done for women already,” she says.

                  Now, though, the big question is how to make sure this drug is available for women who need it the most — women in the poor, remote areas of the world, where maternal mortality is the highest.

                  That’s, I think, the million dollar question,” Kruk says. “We in global health have a number of tools that seem very effective in large clinical trials. But then when it comes time to use them for all women, we see very large gaps in implementation.”

                  Let’s block ads! (Why?)


                  No Image

                  Cord-Cutting Leads ESPN To Target On-Air Personalities In Massive Layoffs

                  ESPN has lost 10 million subscribers since 2011. Today, to cut costs, the sports network is expected to lay off 100 employees. NPR’s Audie Cornish talks to John Ourand of the Sports Business Journal.

                  AUDIE CORNISH, HOST:

                  It’s a brutal day at ESPN. The sports television giant has been handing out pink slips to dozens of on-air personalities. As many as a hundred layoffs are expected. And this comes two years after the company laid off 350 off-air employees. ESPN has traditionally been a profit-generating machine for its parent company Disney but the network has lost millions of subscribers the past few years, as cable’s cord-cutting trend has cut directly into the company’s bottom line.

                  To learn more about this, we turn to John Ourand of the Sports Business Journal. Welcome to the program.

                  JOHN OURAND: Thank you, Audie.

                  CORNISH: So tell us a little bit more about the financial bind that led to today’s layoffs.

                  OURAND: Well, it’s not only the subscriber loss which is huge and it’s really affecting all cable channels. ESPN used to be in close to a hundred million houses and now it’s in less than 87 million homes according to Nielsen. And ESPN gets about $7 per subscriber per month. And so that loss ends up being a lot of money. But combined with that – losses, ESPN has been paying more and more and more for sports rights.

                  They just started a multibillion dollar NBA agreement in the fall and they have to now pay that. And so the finances that used to work when they were in a hundred million homes, they don’t work as well anymore.

                  CORNISH: Meanwhile, more than a quarter of U.S. households apparently don’t subscribe to cable or satellite services. It’s a percentage that has been on the rise in recent years. Has ESPN prepared itself for this world where there are fewer people subscribing to cable packages?

                  OURAND: I think that’s what they’re trying to do today. So they’re trying to – what they call rightsizing, which is an awful corporate word for letting go of good executives and good talent. And they’re just trying to be leaner and move forward in the digital future.

                  CORNISH: So what does that look like for consumers?

                  OURAND: Later this year, ESPN is going to launch an over-the-top service. That means that you don’t need to have – be a cable subscriber to get it. And you’ll be able to stream games to your computer. It’s not going to be the best games. Those are still going to be on the cable ESPN because they still want to support the cable industry because that’s what pays the bills for them.

                  CORNISH: So is this a little bit like what HBO has done, offering a parallel streaming app?

                  OURAND: Exactly. And it’s what all the networks are now looking into doing ’cause they are realizing the need to go directly to the consumer ’cause consumers, especially younger consumers, are not consuming cable.

                  CORNISH: Now, the two groups hardest hit by the cuts so far are the reporters. For instance, Ed Werder, who covered the NFL for 17 years for ESPN, frankly, just about anyone who’s connected to the NHL. But so far, it seems like the talking-head-types are safe. What does this tell you about where they’re taking the programming?

                  OURAND: So ESPN is viewing their programming in two different ways. One is the live games. And then the second thing that they’re doing is SportsCenter is a highlight show that has been a staple of ESPN since ESPN launched. But the problem is people see their highlights in real time almost on their smartphones. So the need for a highlight show like SportsCenter doesn’t work as well.

                  So what they’re trying to do now is that they’re producing these SportsCenters around specific personalities. They have Scott Van Pelt around midnight. They have Jemele Hill at 6 o’clock. And so they’re really counting on the fact that these personalities are going to be able to drive ratings in a way that traditional highlight shows don’t do anymore.

                  CORNISH: The situation sounds bad because they just made so much money but they still make a lot of money. I mean, you talked about cable carriers paying upwards of $7 for every customer who gets ESPN in a bundle.

                  OURAND: Yeah. Don’t cry for ESPN, Audie, absolutely not. They are still profitable. And they still bring in a lot of money. The problem is they just don’t bring as much money as they did before and that’s something that’s concerning.

                  CORNISH: John Ourand. He writes for the Sports Business Journal. Thank you so much for speaking with us.

                  OURAND: Thank you, Audie.

                  (SOUNDBITE OF THE BUDOS BAND’S “T.I.B.W.F.”)

                  Copyright © 2017 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

                  NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

                  Let’s block ads! (Why?)


                  No Image

                  Doctor Ian Malcom Is Heading Back to Jurassic Park for 'Jurassic World 2'

                  The Jurassic Park franchise have never kept much character continuity between the sequels. The Lost World’s main returning player was Jeff Goldblum’s Ian Malcolm. But then he cycled out and Dr. Grant (Sam Neil) came back for Jurassic Park 3, with a very small cameo from Dr. Sattler (Laura Dern). None of them returned for Jurassic World, which instead brought back only two characters from the franchises’ past: Dr. Wu (B.D. Wong) and the t-rex.

                  Sticking with that pattern of cycling people in and out, The Hollywood Reporter has just announced Jeff Goldblum will be back for the sequel to Jurassic World.

                  There’s no word yet on how big of a role the wise-cracking, sexy mathematician will have in the story, but then again we also don’t really know anything about the story at this point except that it’s supposedly darker and scarier. All we know for sure is that J.A. Bayona (A Monster Calls) is directing from a script by Colin Trevorrow and Derek Connolly (Jurassic World). Bryce Dallas Howard and Chris Pratt are returning, and they’ll be joined by new dino-bait James Cromwell, Toby Jones, and Justice Smith.

                  [embedded content]

                  Jurassic World 2, which isn’t its actual title, will hit theaters on June 22, 2018.

                  Follow @PeterSHall Follow @MoviesDotCom

                  Let’s block ads! (Why?)